BRCA1-like profile predicts benefit of tandem high dose epirubicin-cyclophospamide-thiotepa in high risk breast cancer patients randomized in the WSG-AM01 trial
by Schouten, Philip (Author)
, Gluz, Oleg (Author)
, Harbeck, Nadia (Author)
, Mohrmann, Svjetlana (Author)
, Diallo‐Danebrock, Raihana (Author)
, Pelz, Enrico (Author)
, Kruizinga, Janneke (Author)
, Velds, Arno (Author)
, Nieuwland, Marja (Author)
, Kerkhoven, Ron M. (Author)
, Liedtke, Cornelia (Author)
, Frick, Markus (Author)
, Kates, Ronald (Author)
, Linn, Sabine C. (Author)
, Nitz, Ulrike (Author)
, Marmé, Frederik (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource